Epistem has appointed David Budd as CEO and a director of the company. He will join Epistem by the middle of April 2016. Budd joins Epistem from Leica Biosystems Amsterdam where he served as general manager. Previously, he served as commercial director at Leica Biosystems Newcastle. Prior to his work at Leica systems, he served as director of marketing at Siemens Healthcare Diagnostics, business unit leader at Bayer Diagnostics, and Sales Manager at Visible Genetics.